New hope for tough bladder cancers: testing a Two-Drug attack
NCT ID NCT07261592
Summary
This study is testing whether adding a drug called entinostat to standard chemotherapy can help control advanced bladder cancer that has stopped responding to initial treatment. It will involve about 29 patients whose cancer cannot be surgically removed and has spread. The main goal is to see if this combination can shrink tumors and delay cancer progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.